Denise M: Precision Hemostasis in Patient Blood Management
Denise M, Bloodless Medicine and Surgery Program Coordinator, shared a post on LinkedIn:
“Sometimes the best work begins with a challenge.
A few weeks ago, I posted an infographic on the value of Patient Blood Management (PBM) during a crisis.
Tomaz Crochemore, critical care physician and hemostasis expert, left a comment that stopped me.
He said the infographic was outstanding.
Then he pushed further. He wanted to see Patient Clot Management and precision hemostatic medicine explicitly woven into the PBM framework.
It was the first time I had heard of Patient Clot Management. While the physiology of bleeding and thrombosis including conditions like DIC is familiar territory in clinical practice, the term Patient Clot Management was new to me.
Crochemore’s work gave language and structure to that complexity.
I visited his profile (who is this guy?), and found his just published article in the Juntendo Medical Journal:
‘Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine.’ That was my a-ha moment.
The dynamic balance between bleeding and thrombosis. Coagulopathy phenotyping. Individualized hemostatic therapy.
He was right. So I went to work.
What emerged is this:
Precision Hemostasis in Patient Blood Management.
A framework that moves beyond anemia and transfusion stewardship into the full spectrum of blood health:
- Identifying coagulopathy phenotypes — sepsis, trauma, cancer, obstetric, ECMO-induced
- Matching therapy to the patient’s actual hemostatic state
- Preventing both bleeding AND thrombosis
Not one-size-fits-all. Precision-guided. Patient at the center.
For me, it expanded how I think about the PBM framework and adds another dimension to the PBM conversation
Thank you, Crochemore, for seeing further and for trusting that a PBM nurse coordinator in Brooklyn would follow you there. It was great collaborating with you.
This infographic is proof. LinkedIn made it possible. ”

Stay updated with Hemostasis Today.
-
Jun 16, 2026, 17:36Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
-
Jun 16, 2026, 17:32Presenting Pivotal Phase 3 Sickle Cell Data at EHA 2026- Agios Pharmaceuticals
-
Jun 16, 2026, 16:17Megan Lynch: Thrilled to Join AstraZeneca
-
Jun 16, 2026, 16:00Denise M: Two Partners, One Mission – Securing the Future of Blood
-
Jun 16, 2026, 15:4910 Posts Not To Miss From EHA 2026
-
Jun 16, 2026, 15:48Yan Leyfman: Can a Blood Test Reveal which Cells in Your Body are Aging Fastest?
-
Jun 16, 2026, 15:24Hiteshi K.C. Chauhan: Oral Anticoagulant Reversal in Major Bleeding and Urgent Surgery
-
Jun 16, 2026, 14:50Abdulrahman Nasiri: Honored to Share our Research Contributions at the EHA 2026
-
Jun 16, 2026, 14:49An Overview of Bernard–Soulier Syndrome – ICHCC